Endocrinology and Metabolism

Original Articles

Diabetes, obesity and metabolism
Association of Abdominal Myosteatosis and Visceral Fat Obesity with Arterial Stiffness: Min Jung Lee, Hong-Kyu Kim, Eun Hee Kim, Sung Jin Bae, Hyo-Jung Nam, Sang Hoon Lee, Chang Hee Jung, Woo Je Lee; Endocrinol Metab. 2026;41(4):543-557. Published online April 8, 2026; DOI: https://doi.org/10.3803/EnM.2025.2734

2,170 View
69 Download

Abstract PDF Supplementary Material PubReader ePub: Background
Arterial stiffness with aging predicts cardiovascular diseases (CVDs) and target organ damage. While sarcopenia has been linked to arterial stiffness, the association of myosteatosis and visceral adiposity with arterial stiffness remains underexplored. As age-related fat redistribution, including myosteatosis and visceral obesity, often precedes overt sarcopenia, their early evaluation may be beneficial in preventing arterial stiffness. Therefore, this cross-sectional study aimed to assess whether myosteatosis and visceral obesity are associated with increased arterial stiffness.
Methods
A total of 6,004 subjects without CVD who underwent abdominal computed tomography and brachial-ankle pulse wave velocity (baPWV) between 2012 and 2013 during health examinations were included. Visceral fat area and total abdominal muscle area (TAMA) were measured at the L3 vertebral level. Muscle quality was assessed using the normal attenuation muscle area (NAMA)/TAMA index, where a lower value indicates a reduced proportion of healthy muscle (NAMA) and a higher presence of myosteatosis.
Results
After adjusting for multiple cardiovascular risk factors, including myosteatosis, visceral obesity was significantly associated with elevated baPWV in men (odds ratio [OR]=1.32; 95% confidence interval [CI]=1.10 to 1.60; P=0.004). In contrast, in women, myosteatosis was significantly associated with elevated baPWV in a fully adjusted model that included visceral obesity (OR=3.26; 95% CI=1.13 to 9.44; P=0.029).
Conclusion
Ectopic fat infiltration, including visceral obesity and myosteatosis, was significantly associated with increased arterial stiffness. Notably, visceral obesity was significantly associated with elevated baPWV in men, while myosteatosis was significantly associated with elevated baPWV in women after adjustment.

Diabetes, Obesity and Metabolism
The Leg Fat to Total Fat Ratio Is Associated with Lower Risks of Non-Alcoholic Fatty Liver Disease and Less Severe Hepatic Fibrosis: Results from Nationwide Surveys (KNHANES 2008–2011): Hyun Min Kim, Yong-ho Lee; Endocrinol Metab. 2021;36(6):1232-1242. Published online November 23, 2021; DOI: https://doi.org/10.3803/EnM.2021.1087

9,877 View
170 Download
9 Web of Science
10 Crossref

Abstract PDF Supplementary Material PubReader ePub

Background
The prevalence of non-alcoholic fatty liver disease (NAFLD) has rapidly increased worldwide. The aim of this study was to investigate whether there is an independent relationship between regional fat distribution, especially leg fat mass, and the presence of NAFLD using nationally representative data in Korea.
Methods
This cross-sectional study analyzed data from 14,502 participants in the Korea National Health and Nutrition Examination Survey 2008 to 2011. Total fat mass, leg fat mass, and appendicular skeletal muscle mass were measured by dual-energy X-ray absorptiometry. Validated NAFLD prediction models and scoring systems for hepatic fibrosis were used.
Results
The leg fat to total fat (LF/TF) ratio showed a negative relationship with many factors, including body mass index, waist circumference, blood pressure, fasting blood glucose, and liver enzyme levels. When the LF/TF ratio and indices of hepatic steatosis were stratified by quartiles, the LF/TF ratio showed a negative correlation with the scoring systems that were used. The LF/TF ratio showed better accuracy in predicting NAFLD than total fat mass or leg fat mass alone. After adjusting for various traditional and lifestyle factors, a low LF/TF ratio remained a risk factor for NAFLD. Among NAFLD subjects, the LF/TF ratio showed a negative relationship with hepatic fibrosis.
Conclusion
A lower LF/TF ratio was markedly associated with a higher risk of hepatic steatosis and advanced hepatic fibrosis using various predictive models in a Korean population. Therefore, the LF/TF ratio could be a useful anthropometric parameter to predict NAFLD or advanced hepatic fibrosis.

Citations

Citations to this article as recorded by

Heterogeneous associations of regional adipose depots with liver fibrosis in U.S. adults
Kuan-Yu Lai, Chun-Yi Wang, Hsian-Han Kao, Wen-Yuan Lin, Tsung-Po Chen
Metabolism Open.2026; 30: 100461. CrossRef
Leg fat-to-total fat ratio improves waist-to-height ratio for discriminating metabolic syndrome: a nationwide cross-sectional study
Sena Hwang, Hyun Min Kim
Journal of Endocrinological Investigation.2026;[Epub] CrossRef
Low leg fat mass is associated with low insulin sensitivity, inflammatory markers, and β-cell dysfunction in non-obese Japanese people
Satomi Minato-Inokawa, Mari Honda, Ayaka Tsuboi-Kaji, Mika Takeuchi, Kaori Kitaoka, Miki Kurata, Bin Wu, Tsutomu Kazumi, Keisuke Fukuo
Scientific Reports.2025;[Epub] CrossRef
Body composition mediates the association between fatty acids and NAFLD risk: a prospective cohort study
Qishan Yang, Xinming Xu, Yue Chen, Zhicheng Zhang, Berty Ruping Song, Liang Sun, Xiang Gao
Journal of Health, Population and Nutrition.2025;[Epub] CrossRef
Waistline to thigh circumference ratio as a predictor of MAFLD: a health care worker study with 2-year follow-up
Xiaoyan Hao, Honghai He, Liyuan Tao, Wei Zhao, Peng Wang
BMC Gastroenterology.2024;[Epub] CrossRef
Regional fat distribution and hepatic fibrosis and steatosis severity in patients with nonalcoholic fatty liver disease and type 2 diabetes
Asieh Mansour, Saeed Pourhassan, Hadis Gerami, Mohammad Reza Mohajeri‐Tehrani, Marziye Salahshour, Ali Abbasi, Elham Madreseh, Sayed Mahmoud Sajjadi‐Jazi
Obesity Science & Practice.2024;[Epub] CrossRef
Insulin Resistance, Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Clinical and Experimental Perspective
Inha Jung, Dae-Jeong Koo, Won-Young Lee
Diabetes & Metabolism Journal.2024; 48(3): 327. CrossRef
Adipose tissue insulin resistance index was inversely associated with gluteofemoral fat and skeletal muscle mass in Japanese women
Satomi Minato-Inokawa, Mari Honda, Ayaka Tsuboi-Kaji, Mika Takeuchi, Kaori Kitaoka, Miki Kurata, Bin Wu, Tsutomu Kazumi, Keisuke Fukuo
Scientific Reports.2024;[Epub] CrossRef
A greater ratio of thigh subcutaneous fat to abdominal fat is associated with protection against non-alcoholic fatty liver disease
Yebei Liang, Peizhu Chen, Siyu Chen, Dan Liu, Fusong Jiang, Zhijun Zhu, Keqing Dong, Li Wei, Xuhong Hou
JHEP Reports.2023; 5(7): 100730. CrossRef
Association between Alcohol Consumption and Metabolic Dysfunction-Associated Steatotic Liver Disease Based on Alcohol Flushing Response in Men: The Korea National Health and Nutrition Examination Survey 2019–2021
Dae Eon Kang, Si Nae Oh
Nutrients.2023; 15(18): 3901. CrossRef

Clinical Study
Effect of Lactobacillus sakei, a Probiotic Derived from Kimchi, on Body Fat in Koreans with Obesity: A Randomized Controlled Study: Soo Lim, Ji Hye Moon, Chol Min Shin, Dahye Jeong, Bongjoon Kim; Endocrinol Metab. 2020;35(2):425-434. Published online June 24, 2020; DOI: https://doi.org/10.3803/EnM.2020.35.2.425

25,820 View
366 Download
64 Web of Science
70 Crossref

Abstract PDF PubReader ePub

Background
The increased prevalence of obesity has led to increases in the prevalence of chronic diseases worldwide. There is interest whether probiotics have an effect on obesity, but the effectiveness and safety of only a few probiotics for the treatment of obesity have been reported. The purpose of this study was to investigate whether ingestion of Lactobacillus sakei (CJLS03) derived from kimchi causes weight loss in people with obesity.
Methods
This randomized, double-blind, placebo-controlled, clinical trial involved 114 adults with a body mass index (BMI) ≥25 kg/m² who were assigned randomly to a CJLS03 or placebo group. The groups received two allocations of either 5×10⁹ colony-forming units of CJLS03/allocation or the equivalent vehicle for 12 weeks. Demographic and biochemical parameters, and body composition including fat and muscle mass were measured at baseline and after 12 weeks. Changes in body fat, weight, and waist circumference were compared between the two treatment groups. Adverse events were monitored during study period.
Results
Body fat mass decreased by 0.2 kg in the CJLS03 group and increased by 0.6 kg in the placebo group (0.8 kg difference, P=0.018). After the 12 weeks, waist circumference was 0.8 cm smaller in the CJLS03 group than in the placebo group (P=0.013). BMI and body weight did not change after the 12 weeks. Adverse events were mild and did not differ between the two groups.
Conclusion
These data suggest that L. sakei (CJLS03) might help people with obesity reduce body fat mass without serious side effects (ClinicalTrials.gov: NCT03248414).

Citations

Citations to this article as recorded by

The novel synbiotic (Lactiplantibacillus plantarum and galacto-oligosaccharides) ameliorates obesity-related metabolic dysfunction: Arginine as a key mediator signaling molecule
Renjie Shi, Jiangpeng Wei, Jin Ye, Xin Song, Xin Yang, Yi Zhang, Songling Liu, Junli Ren, Danna Wang, Zhenting Zhao, Zhigang Liu, Yutang Wang, Beita Zhao, Chunxia Xiao, Xiaoshuang Dai, Lianzhong Ai, Xuebo Liu
Journal of Advanced Research.2026; 81: 111. CrossRef
Nutritional Status in Obesity: A Comprehensive Narrative Review of Dysbiosis, Micronutrient Deficiencies and the Effects of Probiotics/Synbiotics
Andra-Diana Cecan, Adriana-Florinela Cătoi, Anca But, Iulia-Ioana Morar
Medicina.2026; 62(3): 458. CrossRef
Efficacy of probiotic supplementation for body weight management in overweight and obese adults: a meta-analysis of randomized controlled trials predominantly from East Asia
Shuying Liu, Kani Ouyang, Xuelian Fang, Huijuan He, Mengying Li
Frontiers in Public Health.2026;[Epub] CrossRef
Re-establishing alliances: “Old Friends” confronting obesity, inflammation, and stress-related psychiatric disorders
Luke W. Desmond, Christopher A. Lowry
Brain Behavior and Immunity Integrative.2026; 15: 100166. CrossRef
Anti-obesity effects of probiotics beyond BMI: a critical review of human clinical trials
Hewa Athapaththuge Duvini Athapaththu, Gargi Dey
Letters in Applied Microbiology.2026;[Epub] CrossRef
Effect of Probiotic and Symbiotic Supplementation on Lipid Parameters in Individuals With Overweight and Obesity: A Systematic Review and Meta‐Analysis
Marcelli de Oliveira Rocha, Gabriel Messenburger, Fernanda Ferreira Nuñez, Isadora Bartz Lindenau, Simone Pieniz
Obesity Reviews.2026;[Epub] CrossRef
KIMCHI: A TRADITIONAL FERMENTED FOOD WITH EMERGING HEALTH IMPLICATIONS
Fatih Erdoğan, Kadriye Toprak
Journal of Advanced Studies in Health Science and Obesity.2026; 2(2): 1. CrossRef
Effects of probiotics and synbiotics on body weight management in individuals with overweight or obesity: a systematic review and meta-analysis of randomized controlled trials
Joungbo Ko, Jisun Chun, Choongsung Yoo, Drew E. Gonzalez, Youngil Lee
Physical Activity and Nutrition.2026; 30(2): 78. CrossRef
Probiotics and Its Application in Obesity as the Most Important Cardiovascular Risk: A Review
Pouneh Pashapour
Plant Biotechnology Persa.2026; 8(2): 82. CrossRef
A review and prospects: Multi-omics and artificial intelligence-based approaches to understanding the effects of lactic acid bacteria and yeast interactions on fermented foods
Jiaman Yuan, Donglin Ma, Yatao Yang, Yuzong Zhao, Haiwei Ren, Xiaogang Liu, Minghui Tan, Kuntai Li
Innovative Food Science & Emerging Technologies.2025; 99: 103874. CrossRef
Efficacy of probiotic supplements in the treatment of sarcopenia: A systematic review and meta-analysis
Yi Wang, Ping Lei, Cheung Kenneth Chat Pan
PLOS ONE.2025; 20(2): e0317699. CrossRef
Probiotics and Prebiotics: Meeting Dietary Requirements for Optimal Health and Planetary Sustainability
Juan Chen, Yifei Yu, SiYuan Sun, Weiru Yu, Yumei Lei, Chenxu Lu, Jianan Zhai, Feirong Bai, Fazheng Ren, Ran Wang
The Journal of Nutrition.2025; 155(8): 2519. CrossRef
Supplementation of mixed Lactobacillus alleviates metabolic impairment, inflammation, and dysbiosis of the gut microbiota in an obese mouse model
Shulin Hou, Ruining Li, Yunyun Zhang, Ping Liang, Haishan Yang, Huili He, Lei Wang, Yaojun Sun, Tianru Jin, Zhizhen Liu, Jun Xie
Frontiers in Nutrition.2025;[Epub] CrossRef
Gut Microbiota Modulation Through Dietary Approaches Targeting Better Health During Metabolic Disorders
Amit Kumar Rai, Monika Yadav, Raj Kumar Duary, Pratyoosh Shukla
Molecular Nutrition & Food Research.2025;[Epub] CrossRef
The effects of probiotic supplementation on body composition, recovery following exercise‐induced muscle damage, and exercise performance: A systematic review and meta‐analysis of clinical trials
Nastaran Mahmoudi Shirkoohi, Hamed Mohammadi, Dler Q. Gallaly, Kurosh Djafarian
Physiological Reports.2025;[Epub] CrossRef
Microbiome, Potential Therapeutic Agents: New Players of Obesity Treatment
Maqsood Ali, Navid Iqbal, Md. Abdur Rakib, Kyung-Ah Lee, Mi-Hwa Lee, Yong-Sik Kim
Journal of Microbiology and Biotechnology.2025;[Epub] CrossRef
Impact of probiotic Lactobacillus plantarum GKM3 on gastrointestinal health in overweight and obese individuals: A randomized clinical trial
You-Shan Tsai, Xin-Bei Lin, Shih-Wei Lin, Yen-Lien Chen, Chin-Lin Hsu, Chin-Chu Chen
Clinical Nutrition ESPEN.2025; 68: 283. CrossRef
Harnessing Probiotics: Exploring the Role of the Gut Microbiome in Combating Obesity
Riyasdeen Anvarbatcha, Faisal Kunnathodi, Amr A. Arafat, Sarfuddin Azmi, Mohammad Mustafa, Ishtiaque Ahmad, Haifa F. Alotaibi
Probiotics and Antimicrobial Proteins.2025; 17(4): 2600. CrossRef
The hidden diversity of food microbiomes
Edoardo Pasolli, Danilo Ercolini
Current Opinion in Food Science.2025; 64: 101318. CrossRef
Effects of multi-strain probiotics supplementation on body adiposity and metabolic profile in individuals with hypertension and overweight following an energy-restricted diet: A randomized clinical trial
Karine Scanci da Silva Pontes, Marcella Rodrigues Guedes, Priscila Guadagno de Souza, Mario Fritsch Toros Neves, Márcia Regina Simas Torres Klein
Clinical Nutrition.2025; 50: 117. CrossRef
Fermented Fruits, Vegetables, and Legumes in Metabolic Syndrome: From Traditional Use to Functional Foods and Medical Applications
Karolina Bernacka, Tomasz Sozański, Alicja Z. Kucharska
Nutrients.2025; 17(12): 1989. CrossRef
Transcriptomic analysis revealed the adaptations of Latilactobacillus sakei to the cold conditions of kimchi fermentation
Min Ji Kim, Ji Young Jeong, Hyun-Sung Kim, In Min Hwang, Woojin Jun, Jong-Hee Lee
Food Research International.2025; 217: 116742. CrossRef
Comparative genomic analysis of Latilactobacillus sakei strains provides new insights into their association with different niche adaptations
Kohei Ito, Yutaro Ito
Microbiology .2025;[Epub] CrossRef
Efficacy and safety of Latilactobacillus sakei LB-P12 in patients with knee osteoarthritis: an exploratory randomized, double-blind, placebo-controlled clinical trial
Bo-Kyung Shine, Qing Li, Mikyung Song, Kyoungsub Song, Jaeseok Shim, Seong-Ho Han
Scientific Reports.2025;[Epub] CrossRef
The Effects of Probiotics Consumption on Blood Pressure, Lipid Profile, Glycemic Indices, and Inflammatory Parameters in Overweight and Obese Adults: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
Safa Sefidgari‐Abrasi, Marziyeh Rahimiyan‐Heravan, Vahid Amiran, Elham Navval‐Esfahlan, Maryam Saghafi‐Asl
Food Science & Nutrition.2025;[Epub] CrossRef
Immunomodulatory Effects of Lactobacillus brevis NES-428 in a Hyperthyroidism Mouse Model: Potential Applications for Graves’ Disease
Min-Gyu Lee, Dong-Hyun Lee, Suzie Kang, Jongho Koh, Cheol-Won Yun
Nutrients.2025; 17(18): 2967. CrossRef
Effect of Lactobacillus spp. Supplementation for Improving Muscle Health: A Systematic Review and Meta-Analysis
Jeong Yeon Im, Eun Jin Jung, Jun Gu Lee, Bok Kyung Han, Ji Youn Hong, Young Jun Kim
Journal of Medicinal Food.2025; 28(9): 842. CrossRef
Latilactobacillus sakei : a candidate probiotic with a key role in food fermentations and health promotion
Leilei Yu, Ying Chen, Hui Duan, Nanzhen Qiao, Gang Wang, Jianxin Zhao, Qixiao Zhai, Fengwei Tian, Wei Chen
Critical Reviews in Food Science and Nutrition.2024; 64(4): 978. CrossRef
Beneficial effects of the probiotics and synbiotics supplementation on anthropometric indices and body composition in adults: A systematic review and meta‐analysis
Saeede Saadati, Kaveh Naseri, Omid Asbaghi, Mohsen Yousefi, Elnaz Golalipour, Barbora de Courten
Obesity Reviews.2024;[Epub] CrossRef
Spore-forming probiotics Weizmannia coagulans isolated from human breast milk improves on the flavor development using micro-cheese platform
Hyejin Choi, Daye Mun, Sangdon Ryu, Min-Jin Kwak, Bum-Keun Kim, Dong-Jun Park, Do-Youn Jeong, Wonseo Park, Sangnam Oh, Younghoon Kim
Food Bioscience.2024; 57: 103550. CrossRef
Latilactobacillus sakei as a starter culture to ferment pepper fruits
Emma Mani-López, Nelly Ramírez-Corona, Aurelio López-Malo
Food and Humanity.2024; 2: 100233. CrossRef
Association between kimchi consumption and obesity based on BMI and abdominal obesity in Korean adults: a cross-sectional analysis of the Health Examinees study
Hyein Jung, Ye-Rang Yun, Sung Wook Hong, Sangah Shin
BMJ Open.2024; 14(2): e076650. CrossRef
Adjunctive administration of parabiotic Lactobacillus sakei CVL-001 ameliorates drug-induced toxicity and pulmonary inflammation during antibiotic treatment for tuberculosis
Hagyu Kim, Eun-Jung Song, Eunsol Choi, Kee Woong Kwon, Jong-Hwan Park, Sung Jae Shin
International Immunopharmacology.2024; 132: 111937. CrossRef
Anti-obesogenic effects of plant natural products: A focus on Korean traditional foods
Gitishree Das, Luis Alfonso Jiménez Ortega, Sandra Gonçalves, J. Basilio Heredia, Maria de Lourdes Gomes Pereira, Anabela Romano, Han-Seung Shin, Jayanta Kumar Patra
Trends in Food Science & Technology.2024; 148: 104470. CrossRef
Efficacy of Lactococcus lactis subsp. lactis LY-66 and Lactobacillus plantarum PL-02 in Enhancing Explosive Strength and Endurance: A Randomized, Double-Blinded Clinical Trial
Mon-Chien Lee, Yi-Ju Hsu, Mu-Tsung Chen, Yi-Wei Kuo, Jia-Hung Lin, Yu-Chieh Hsu, Yen-Yu Huang, Ching-Min Li, Shin-Yu Tsai, Ko-Chiang Hsia, Hsieh-Hsun Ho, Chi-Chang Huang
Nutrients.2024; 16(12): 1921. CrossRef
Improvement and application of recommended food score for hypertension in Korean adults: the Korean Genome and Epidemiology Study
Jiyoung Hwang, Jeongsu Kim, Hyesook Kim
Frontiers in Nutrition.2024;[Epub] CrossRef
Use of probiotics in preventing and treating excess weight and obesity. A systematic review
Belén Torres, María C. Sánchez, Leire Virto, Arancha Llama‐Palacios, María J. Ciudad, Luis Collado
Obesity Science & Practice.2024;[Epub] CrossRef
Association between dietary patterns and obesity: a longitudinal prospective cohort study
L.-J. Tan, S.-J. Oh, B. Nasan-Ulzii, W. Lee, S.W. Hong, S. Shin
Public Health.2024; 234: 217. CrossRef
Health Benefits of Kimchi, Sauerkraut, and Other Fermented Foods of the Genus Brassica
Sabina Fijan, Polona Fijan, Lei Wei, Maria L. Marco
Applied Microbiology.2024; 4(3): 1165. CrossRef
The Skin Histopathology of Pro- and Parabiotics in a Mouse Model of Atopic Dermatitis
Hun Hwan Kim, Se Hyo Jeong, Min Yeong Park, Pritam Bhagwan Bhosale, Abuyaseer Abusaliya, Jeong Doo Heo, Hyun Wook Kim, Je Kyung Seong, Tae Yang Kim, Jeong Woo Park, Byeong Soo Kim, Gon Sup Kim
Nutrients.2024; 16(17): 2903. CrossRef
Effects of Kimchi Intake on the Gut Microbiota and Metabolite Profiles of High-Fat-Induced Obese Rats
Dong-Wook Kim, Quynh-An Nguyen, Saoraya Chanmuang, Sang-Bong Lee, Bo-Min Kim, Hyeon-Jeong Lee, Gwang-Ju Jang, Hyun-Jin Kim
Nutrients.2024; 16(18): 3095. CrossRef
Revisiting the potential anti-obesity effects of kimchi and lactic acid bacteria isolated from kimchi: a lustrum of evidence
Anshul Sharma, Hae-Jeung Lee
Journal of Ethnic Foods.2024;[Epub] CrossRef
Impact of D-allulose consumption on Enteric pathogens in human gut Microbiota: A randomized controlled trial study
Heekuk Park, Jihye Baek, Se Young Park, Soonok Sa, Ji Eun Jun, Min Jeong Kim, In-Kyung Jeong, Wonyong Kim
Journal of Functional Foods.2024; 122: 106555. CrossRef
The effect of probiotic and synbiotic supplementation on lipid parameters among patients with cardiometabolic risk factors: a systematic review and meta-analysis of clinical trials
Zeinab Ghorbani, Asma Kazemi, Theda U.P. Bartolomaeus, Fahimeh Martami, Morvarid Noormohammadi, Arsalan Salari, Ulrike Löber, Heydar Ali Balou, Sofia K. Forslund, Marjan Mahdavi-Roshan
Cardiovascular Research.2023; 119(4): 933. CrossRef
Impact of probiotics on muscle mass, muscle strength and lean mass: a systematic review and meta‐analysis of randomized controlled trials
Konstantinos Prokopidis, Panagiotis Giannos, Richard Kirwan, Theocharis Ispoglou, Francesco Galli, Oliver C. Witard, Konstantinos K. Triantafyllidis, Konstantinos S. Kechagias, Jordi Morwani‐Mangnani, Andrea Ticinesi, Masoud Isanejad
Journal of Cachexia, Sarcopenia and Muscle.2023; 14(1): 30. CrossRef
Anti-obesity potential of heat-killed Lactiplantibacillus plantarum K8 in 3T3-L1 cells and high-fat diet mice
Kyoung Ok Jang, Jung Seo Choi, Kyeong Hun Choi, Seongjae Kim, Hangeun Kim, Dae Kyun Chung
Heliyon.2023; 9(1): e12926. CrossRef
Effect of Lactobacillus plantarum LMT1-48 on Body Fat in Overweight Subjects: A Randomized, Double-Blind, Placebo-Controlled Trial
Minji Sohn, Hyeyoung Jung, Woo Shun Lee, Tai Hoon Kim, Soo Lim
Diabetes & Metabolism Journal.2023; 47(1): 92. CrossRef
Effect of kimchi intake on body weight of general community dwellers: a prospective cohort study
Li-Juan Tan, Ye-Rang Yun, Sung Wook Hong, Sangah Shin
Food & Function.2023; 14(4): 2162. CrossRef
Effects of Probiotics on Intermediate Cardiovascular Outcomes in Patients with Overweight or Obesity: A Systematic Review and Meta-Analysis
Frank Mayta-Tovalino, Carlos Diaz-Arocutipa, Alejandro Piscoya, Adrian V. Hernandez
Journal of Clinical Medicine.2023; 12(7): 2554. CrossRef
Effects of kimchi on human health: a scoping review of randomized controlled trials
Eunhye Song, Lin Ang, Hye Won Lee, Myung-Sunny Kim, You Jin Kim, Daija Jang, Myeong Soo Lee
Journal of Ethnic Foods.2023;[Epub] CrossRef
Randomized controlled trials reporting the effects of probiotics in individuals with overweight and obesity: A critical review of the interventions and body adiposity parameters
Marcella Rodrigues Guedes, Karine Scanci da Silva Pontes, Maria Inês Barreto Silva, Mario Fritsch Neves, Márcia Regina Simas Torres Klein
Clinical Nutrition.2023; 42(6): 835. CrossRef
Roles of the gut microbiome in weight management
Rachel N. Carmody, Jordan E. Bisanz
Nature Reviews Microbiology.2023; 21(8): 535. CrossRef
Does gut microbiota affect the success of weight loss? Evidence and speculation
Małgorzata Moszak, Marta Pelczyńska, Agnieszka Wesołek, Dominika Stenclik, Paweł Bogdański
Nutrition.2023; 116: 112111. CrossRef
Certain Fermented Foods and Their Possible Health Effects with a Focus on Bioactive Compounds and Microorganisms
Gülsüm Deveci, Elif Çelik, Duygu Ağagündüz, Elena Bartkiene, João Miguel F. Rocha, Fatih Özogul
Fermentation.2023; 9(11): 923. CrossRef
The gut microbiome in the fight against obesity: The potential of dietary factors
Jamil Ahmad, Imran Khan, Gokhan Zengin, Mohamad Fawzi Mahomoodally
The FASEB Journal.2023;[Epub] CrossRef
Effect of Continuous Ingestion of Bifidobacteria and Inulin on Reducing Body Fat: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Comparison Study
Yuhei Baba, Yasuo Saito, Mei Kadowaki, Naoki Azuma, Daisuke Tsuge
Nutrients.2023; 15(24): 5025. CrossRef
A Review of the Health Benefits of Kimchi Functional Compounds and Metabolites
Hyun Ju Kim, Min Sung Kwon, Hyelyeon Hwang, Ha-Sun Choi, WooJe Lee, Sang-Pil Choi, Haeun Jo, Sung Wook Hong
Microbiology and Biotechnology Letters.2023; 51(4): 353. CrossRef
Efficacy and Safety of Lactobacillus plantarum K50 on Lipids in Koreans With Obesity: A Randomized, Double-Blind Controlled Clinical Trial
Minji Sohn, Ga Yoon Na, Jaeryang Chu, Hyunchae Joung, Byung-Kook Kim, Soo Lim
Frontiers in Endocrinology.2022;[Epub] CrossRef
Changes in systolic blood pressure, postprandial glucose, and gut microbial composition following mango consumption in individuals with overweight and obesity
Justine Keathley, Michèle Kearney, Véronique Garneau, Juan de Toro-Martín, Thibault V. Varin, Geneviève Pilon, Patrick Couture, André Marette, Marie-Claude Vohl, Charles Couillard
Applied Physiology, Nutrition, and Metabolism.2022; 47(5): 565. CrossRef
Host—microbial interactions in metabolic diseases: from diet to immunity
Ju-Hyung Lee, Joo-Hong Park
Journal of Microbiology.2022; 60(6): 561. CrossRef
Effect of MED-02 Containing Two Probiotic Strains, Limosilactobacillus fermentum MG4231 and MG4244, on Body Fat Reduction in Overweight or Obese Subjects: A Randomized, Multicenter, Double-Blind, Placebo-Controlled Study
Young Gyu Cho, Yun Jun Yang, Yeong Sook Yoon, Eon Sook Lee, Jun Hyung Lee, Yulah Jeong, Chang Ho Kang
Nutrients.2022; 14(17): 3583. CrossRef
Evaluation of metabolic activities and probiotic characteristics of two Latilactobacillus sakei strains isolated from pastırma
Emine Dincer, Merih Kivanc
World Journal of Microbiology and Biotechnology.2022;[Epub] CrossRef
Correlation between autochthonous microbial communities and flavor profiles during the fermentation of mustard green paocai (Brassica juncea Coss.), a typical industrial-scaled salted fermented vegetable
Dongdong Wang, Gong Chen, Yao Tang, Jiayi Li, Runqiu Huang, Meizuo Ye, Jianying Ming, Yalong Wu, Fei Xu, Xingyue Lai, Qisheng Zhang, Wenxue Zhang
LWT.2022; 172: 114212. CrossRef
Therapeutic and Improving Function of Lactobacilli in the Prevention and Treatment of Cardiovascular-Related Diseases: A Novel Perspective From Gut Microbiota
Xin Zhao, Xinqin Zhong, Xiao Liu, Xiaoying Wang, Xiumei Gao
Frontiers in Nutrition.2021;[Epub] CrossRef
Don’t Worry, Heavy Moms; Just Eat Your Broccoli (or Kimchi)!
Sun-Kyung Lee
Molecules and Cells.2021; 44(6): 422. CrossRef
Effects of probiotics on body adiposity and cardiovascular risk markers in individuals with overweight and obesity: A systematic review and meta-analysis of randomized controlled trials
Karine Scanci da Silva Pontes, Marcella Rodrigues Guedes, Michelle Rabello da Cunha, Samanta de Souza Mattos, Maria Inês Barreto Silva, Mario Fritsch Neves, Bianca Cristina Antunes Alves Marques, Márcia Regina Simas Torres Klein
Clinical Nutrition.2021; 40(8): 4915. CrossRef
Health-Promoting Constituents and Selected Quality Parameters of Different Types of Kimchi: Fermented Plant Products
Anna Korus, Emilia Bernaś, Jarosław Korus, Eduard Hernández
International Journal of Food Science.2021; 2021: 1. CrossRef
Effects of Probiotics and Synbiotics on Weight Loss in Subjects with Overweight or Obesity: A Systematic Review
Valentina Álvarez-Arraño, Sandra Martín-Peláez
Nutrients.2021; 13(10): 3627. CrossRef
ADJUVANT AND BENEFICIAL PROBIOTIC THERAPY FOR WOMEN HEALTH
Igori Balta, Eugenia Butucel, Valentyn Mohylyuk
Romanian Archives of Microbiology and Immunology.2021; 80(2): 151. CrossRef
Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategies
Jean Bousquet, Jean-Paul Cristol, Wienczyslawa Czarlewski, Josep M. Anto, Adrian Martineau, Tari Haahtela, Susana C. Fonseca, Guido Iaccarino, Hubert Blain, Alessandro Fiocchi, G. Walter Canonica, Joao A. Fonseca, Alain Vidal, Hak-Jong Choi, Hyun Ju Kim,
Clinical and Translational Allergy.2020;[Epub] CrossRef

Relationship between Adiponectin, Leptin and Body Fat in Men with Hypogonadism Before and After Testosterone Treatment.: Sang Wan Kim, Joon Ku Kang, Do Joon Park, Chan Soo Shin, Kyung Soo Park, Seong Yeon Kim, Bo Youn Cho, Hong Kyu Lee; J Korean Endocr Soc. 2004;19(5):473-484. Published online October 1, 2004

2,296 View
20 Download

Abstract PDF: BACKGROUND
Testosterone replacement therapy in men with hypogonadism improves sexual function, decreases body fat, and increases the mass and function of lean muscle. These beneficial effects of testosterone replacement therapy are accompanied by slight lowering of the high density lipoprotein (HDL) cholesterol levels, increase in the hematocrit/hemoglobin ratio and size of the prostate gland. It is presently unknown whether the effect of testosterone on body fat could also reduce the risk of atherosclerotic disease associated with obesity. We investigated the relationship between body fat and blood leptin and adiponectin levels to elucidate the effect of testosterone on body fat metabolism, as well as the effect of testosterone on lipid and bone metabolism. METHODS: We selected 28 men, who were hypogonadal (mean serum testosterone+/-SD, 22.3+/-35.3 ng/dL) due to an organic disease, and them with oral testosterone (testosterone undecanoate) for 12 months. We measured the body composition, serum leptin, plasma adiponectin, biochemical bone markers, bone mineral density, prostate-specific antigen, and serum lipids before and 3, 6 and 12 months after treatment. We analyzed the relationship between body fat and blood leptin and adiponectin levels. RESULTS: The mean serum testosterone concentration reached the subnormal range after 6 months of treatment, which remained for the duration of treatment. The fat mass decreased and muscle mass increased, not within the first 6 months, but principally within 12 months (p<0.05). Although the decrease in the serum leptin level was not statistically significant, there were positive correlations between the leptin level and fat mass before and after 6 months of treatment (p<0.05). The plasma adiponectin did not increase or correlate with body fat parameters. The bone mineral densities of the lumbar spine (L2-L4) and femoral neck did not increased, but the serum osteocalcin and urine N-telopeptide were significantly decreased (p<0.05 and <0.01, respectively). The HDL-cholesterol decreased, principally within the first 6 months (p<0.01), but the total and LDL cholesterols, and the triglycerides remained unchanged during the course of treatment. There was also no change in prostate-specific antigen. CONCLUSION: Twelve months of oral testosterone replacement in men with hypogonadism improved body composition and bone metabolism, but demonstrated subnormal serum testosterone levels, had no effect on the leptin and adiponectin levels and decrease in HDL-cholesterol levels. It will be necessary to examine the long-term effects of testosterone replacement on the incidence of cardiovascular events as well as cardiovascular risk factors in men with hypogonadism

Effects of B3-adrenergic Receptor Gene Mutation on the Body Fat Distribution and Weight Loss in Obese Subjects.: Sung Kil Lim, Young Duk Song, Hyun Chul Lee, Kap Bum Huh, Kyung Rae Kim, Seok Won Park, Seok Joo Kwon, Eun Young Cho, Jong Ho Lee; J Korean Endocr Soc. 1998;13(4):590-600. Published online January 1, 2001

1,939 View
19 Download

Abstract PDF: BACKGROUND
Recently, missense mutation of the B3-adrenergic receptor gene has been shown to be associated with early onset of type 2 diabetes, abdominal obesity and an increased capacity to gain weight. This study was performed to investigate the effects of Trp64Arg mutation in the B3-adrenergic receptor gene on body fat distribution and weight loss in obese subjects. METHODS: Determination of the B3-adrenergic receptor gene mutation with restriction enzyme digestion method, anthropometry, various biochemical studies, including oral glucose tolerance test were performed in 99 obese and 35 control subjects. Body fat distributions were also evaluated by computerized tomography before and after weight-reduction program. RESULTS: I) There were no differences in the frequencies of Trp64Arg mutation in the B3-adrenergic receptor gene between obese and control subjects (15.2 vs 12.9 %). 2) The obese subjects with Trp64Arg mutation had higher waist to hip circumference ratio(WHR) (0.93 +/- 0.05 vs 0.87 +/- 0.04, p<0.001), visceral fat area (115.0 +/- 25.9 vs 86.4 +/- 41.4 cm, p=0.01), but decreased plasma free fatty acid (618.0 +/- 163.1 vs 817.5 +/- 248.2 pEq/L, p=0.001), and triglyceride level (118.7 +/- 36.2 vs 158.4 +/- 105.8 mg/dL, p=0.015) than those without mutation. 3) The obese subjects with Trp64Arg mutation had smaller decreases in weight (-3.4 vs -5.1 kg, p<0.001), body fat content (-2.1 vs -3.8 %, p<0.001), WHR (-0.01 vs -0.03, p=0.025), and abdominal fat masses (total, subcutaneous, and visceral fat) after weight-reduction program than those without mutation. CONCLUSION: Trp64Arg mutation in the B3-adrenergic receptor gene might be one of genetic loci contributing to central obesity and a predictor of difficulty in losing weight in obese subjects.

First
Prev
Page of 1
Next
Last

Search